Cytek Biosciences Inc
F:8EQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cytek Biosciences Inc
F:8EQ
|
US |
|
P
|
Public Power Corporation SA
XMUN:PU8
|
GR |
|
Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
|
ES |
|
A
|
Adtalem Global Education Inc
F:DVY
|
US |
|
A
|
Appen Ltd
OTC:APPEF
|
AU |
|
B
|
BBMG Corp
XMUN:9BM
|
CN |
|
Novavax Inc
NASDAQ:NVAX
|
US |
|
Z
|
Zimmer Biomet Holdings Inc
SIX:ZBH
|
US |
|
C
|
Coca-Cola Consolidated Inc
F:CC5
|
US |
|
A
|
Alkane Resources Ltd
XMUN:AK7
|
AU |
Wall St Price Targets
8EQ Price Targets Summary
Cytek Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 8EQ is 4.65 EUR with a low forecast of 3.85 EUR and a high forecast of 6.31 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8EQ's stock price target?
Price Target
4.65
EUR
According to Wall Street analysts, the average 1-year price target for 8EQ is 4.65 EUR with a low forecast of 3.85 EUR and a high forecast of 6.31 EUR.
What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
8%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Cytek Biosciences Inc?
Projected CAGR
10%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 10%.
